Inactivated polio vaccine: Its proposed role in the final stages of polio eradication

Pan African Medical Journal

Volumn 14, Issue , 2013, Pages

  Davis, Robert ^a   Biellik, Robin ^b  

^a American Red Cross   (Kenya)

^b Consulting Epidemiologist ^*  (Switzerland)

Author keywords

Circulating vaccine derived poliovirus; Financial sustainability; Immunization; Inactivated polio vaccine; Oral polio vaccine; Polio eradication

Indexed keywords

ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE;

ARTICLE; DEVELOPING COUNTRY; DRUG COST; DRUG EFFECT; DRUG EFFICACY; ENDEMIC DISEASE; FUNDING; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INVESTMENT; MUCOSAL IMMUNITY; NONHUMAN; POLIOMYELITIS; POLIOMYELITIS VIRUS; SEROCONVERSION; TREATMENT PLANNING; VIRUS TRANSMISSION; CHILD; CIRCULATING VACCINE DERIVED POLIOVIRUS; DISEASE ERADICATION; FINANCIAL SUSTAINABILITY; HEALTH; IMMUNIZATION; INACTIVATED POLIO VACCINE; POLIO ERADICATION;

CIRCULATING VACCINE DERIVED POLIOVIRUS; FINANCIAL SUSTAINABILITY; IMMUNIZATION; INACTIVATED POLIO VACCINE; ORAL POLIO VACCINE; POLIO ERADICATION;

CHILD; DISEASE ERADICATION; HUMANS; POLIOMYELITIS; POLIOVIRUS VACCINE, INACTIVATED; WORLD HEALTH;

EID: 84876492593     PISSN: 19378688     EISSN: None     Source Type: Journal    
DOI: 10.11604/pamj.2013.14.102.2580     Document Type: Article

References (23)

1. Kew O, Morris-Glasgow V, Landaverde M et al. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science. 2002 Apr 12;296(5566):356-9.
2. Davis R, Wright PF. Circulating vaccine derived poliovirus and the polio eradication endgame. Pan Afr Med J. 2012;12:109.
3. Chen-Fu Yang, Tary Naguib, Su-Ju Yang et al. Circulation of Endemic Type 2 Vaccine-Derived Poliovirus in Egypt from 1983 to 199 J Virol. 2003 August; 77(15): 8366-8377.
4. Alison Wringe, Paul EM Fine, Roland W Sutter, Olen M Kew. Estimating the Extent of Vaccine-Derived Poliovirus Infection. PLoS ONE. 2008; 3(10): e3433.
5. CDC - Vaccines and Immunizations. Vaccine-Associated Paralytic Poliomyelitis. Available at http://www.cdc.gov/vaccines/pubs/pinkbook/polio.html#adverse. Accessed 24 January 2013.
6. Polio Eradication Initiative. POLIO ERADICATION AND ENDGAME STRATEGIC PLAN (2013-2018). Available at: http://www.polioeradication.org/Portals/0/Document/Resources/StrategyWork/EndGameStratPlan_20130111_ENG.pdf. Accessed 24 January 2013.
7. Thompson KM, Tebbens R J D. Current polio global eradication and control policy options: perspectives from modeling and prerequisites for oral poliovirus vaccine cessation. Expert Review of Vaccines. 2012 April; 11(4):449-459.
8. Margareta Böttiger, Bo Zetterberg, Carl-Rune Salenstedt. Seroimmunity to poliomyelitis in Sweden after the use of inactivated poliovirus vaccine for 10 years. Bull World Health Organ. 1972; 46(2): 141-149.
9. Böttiger M. The elimination of polio in the Scandinavian countries. Public Health Rev. 1993-1994;21(1-2):27-33.
10. Hird TR, Grassly NC. Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge. PLoS Pathog. 2012;8(4):e1002599.
11. Cuba IPV Study Collaborative Group. Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba. N Engl J Med. 2007 Apr 12;356(15):1536-44.
12. Laassri M, Lottenbach K, Belshe R, Wolff M et al. Effect of different vaccination schedules on excretion of oral poliovirus vaccine strains. J Infect Dis. 2005 Dec 15;192(12):2092-8.
13. Murdin AD, Barreto L, Plotkin S. Inactivated poliovirus vaccine: past and present experience. Vaccine. 1996 Jun;14(8):735-46.
14. Global eradication of Poliomyelitis. Report of the fifth meeting of the Global Technical Consultative Group for Poliomyelitis Eradication, Geneva, 8-10 May 2000. Unpublished W.H.O. report. Available at:http://www.who.int/vaccines-documents/DocsPDF00/www553.pdf. Accessed 23 January 2013.
15. Nathanson N, Kew OM. Poliovirus vaccines: past, present, and future. Arch Pediatr Adolesc Med. 2011 Jun;165(6):489-91.
16. Paul Y. OPV cannot eradicate polio from India: do we need any further evidence? Vaccine. 2008 Apr 16;26(17):2058-61.
17. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1997 Jan 24;46(RR-3):1-25.
18. Alvis N, De la Hoz F, Narváez J. Economic impact of introducing the injectable inactivated polio vaccine in Colombia. Rev Panam Salud Publica. 2010 May;27(5):352-9.
19. Schoub BD. Introduction of inactivated polio vaccine (IPV) into the routine immunization schedule of South Africa. Vaccine. 2012 Sep 7;30 Suppl 3:C35-7.
20. Poliomyelitis: intensification of the global eradication initiative/Report by the Secretariat. Available at http://apps.who.int/gb/ebwha/pdf_files/EB132/B132_17-en.pdf. Accessed 20 December 2012.
21. Sabin IPV. Available at http://www.polioeradication.org/tabid/408/iid/127/Default.aspx. Accessed 24 January 2013.
22. Thompson KM, Tebbens RJ. Eradication versus control for poliomyelitis: an economic analysis. Lancet. 2007 Apr 21;369(9570):1363-71.
23. Thompson KM, Tebbens RJ, Pallansch MA, Kew OM et al. The risks, costs, and benefits of possible future global policies for managing polioviruses. Am J Public Health. 2008 Jul;98(7):1322-30.